Brendha Lang Camboim

Brendha Lang Camboim

Auto-generated profile, based on publicly available information

Brendha Lang Camboim

Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2025 in Brazilian Journal of Analytical Chemistry
Verified
Journal Article
Closed access
AMAmanda Mohr
Amanda Mohr
BCBrendha Camboim
Brendha Camboim
AMAndreas Mendez
Andreas Mendez
CGCássia Garcia
Cássia Garcia
MSMartin Steppe
Martin Steppe
The main goal of Green Analytical Chemistry (GAC) is to reduce the use of hazardous chemicals and waste generation in analytical procedures without compromising method performance. Over the years, several metrics tools were introduced to measure the environmental impact and greenness of analytical procedures. In this context, this paper aims to present an overview of the most used GAC metrics in analytical chemistry, highlighting their criteria, advantages, disadvantages, and comparing their applicability. After extensive research, the metrics selected to be addressed were: National Environmental Method Index (NEMI), Analytical Eco-scale, Modified Green Analytical Procedure Index (MoGAPI), and Analytical GREEnness Metric (AGREE). NEMI is one of the oldest GAC metrics, describing the greenness of the method by a simple pictogram. Analytical Eco-Scale is based on subtracting penalty points from a total score of 100 points. MoGAPI uses a pictogram made up of fifteen categories and a total score to display the greenness of the analytical procedure. AGREE is represented as a circular pictogram divided into 12 parts, where each part corresponds to a principle of GAC. Each discussed metric has its own advantages and disadvantages; however, AGREE stands out as the most widely used and comprehensive GAC metric, applicable to several techniques. Although time-consuming, ideally, the best approach is to apply all metrics in combination to gain as much information as possible.

7 June 2025 in Separation Science Plus
Verified
Journal Article
Open access
RSRafaela Martins Sponchiado
Rafaela Martins Sponchiado
BCBrendha Lang Camboim
Brendha Lang Camboim
JSJulia Medeiros Sorrentino
Julia Medeiros Sorrentino
LCLeticia Malgarim Cordenonsi
Leticia Malgarim Cordenonsi
ADAlexsandro Dallegrave
Alexsandro Dallegrave
CGCássia Virginia Garcia
Cássia Virginia Garcia
The focus of the present study was the monitoring of ambrisentan (AMB) in vitro biotransformation by two fungal cultures: Aspegillus niger ATCC 9029 and Penicillium mineoluteum URM 6889. This drug is a selective endothelin Type A, receptor antagonist, used for pulmonary arterial hypertension. In vitro metabolism study was carried out by incubating AMB with fungus and culture medium under controlled conditions for further analysis of metabolites formed through an alternative method. After incubation for 240 hours with A. niger , drug was metabolized into two substances: one is known (M2) with 3.75 min retention time and another unknown (M3) at 4.37 min retention time in high performance liquid chromatography–diode array detector method (HPLC‐DAD). Structures were suggested by using ultra high performance liquid chromatography/quadrupole time‐of‐flight mass spectrometry (UHPLC‐QTOF/MS) method. When drug was submitted to biotransformation with P. mineoluteum , no different signals than those formed in the controls were observed, demonstrating it is not adequate to the purpose. The findings indicate that fungi A. niger could be used to generate mammalian metabolites of AMB on a small scale and can also be used as reference standard for identification and analytical tests of mammalian metabolites of this drug.

5 May 2026 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Open access
BCBrendha Lang Camboim
Brendha Lang Camboim
BBBruna Silveira Bersagui
Bruna Silveira Bersagui
SASílvia Helena de Oliveira Almeida
Sílvia Helena de Oliveira Almeida
MAMárcio Vinícius Ayres
Márcio Vinícius Ayres
AMAndreas Sebastian Loureiro Mendez
Andreas Sebastian Loureiro Mendez
CGCássia Virginia Garcia
Cássia Virginia Garcia
Levothyroxine sodium (SLT4) is the sodium salt of the thyroid hormone thyroxine, being the first-choice replacement therapy in hypothyroid disease. Congenital hypothyroidism affects infants, and represents one of the most common preventable causes of intellectual disability worldwide. In Brazil and other countries, tablets are the only dosage form of SLT4 for oral use. Pediatric patients and adults unable to swallow require SLT4 extemporaneously prepared in the hospital's routine, which can compromise safety. On the other hand, oral SLT4 solutions are available in USA, Italy, Spain, and United Kingdom. The aim of this work was to develop a SLT4 oral liquid formulation and assess its stability during 63 days under 4 °C, 25 °C and 40 °C, comparing amber glass bottles and sachet packing. In the development stage, excipients were evaluated by data tools (STEP and PERA) and the most suitable for pediatric use were chosen. An HPLC method was developed and validated to analyze SLT4 content, and forced degradation outcomes were investigated through UPLC-MS. Every 7 days, pH, drug amount, visual aspect, organoleptic properties and microbiological content were analyzed. The SLT4 30 µg/mL oral solution showed adequate physical chemical and microbiological characteristics. It was stable for 63 days when stored both in sachet and amber glass bottles at 4 °C and 25 °C. Six major degradation products structures were proposed after stress testing evaluations. It was possible to obtain a simple STL4 oral solution, with pediatric-safe excipients and dosing flexibility, representing an alternative for hospital treatment of hypothyroidism.

19 May 2026 in Hospital Pharmacy
Verified
Journal Article
Closed access
BBBruna S. Bersagui
Bruna S. Bersagui
GOGabriela A. de Oliveira
Gabriela A. de Oliveira
BCBrendha L. Camboim
Brendha L. Camboim
SASílvia H. O. de Almeida
Sílvia H. O. de Almeida
MAMárcio V. Ayres
Márcio V. Ayres
CGCássia V. Garcia
Cássia V. Garcia
Purpose: Losartan potassium is an antihypertensive drug commercialized only as tablets. As an alternative to the hospital pediatric extemporaneous preparations, it was developed a sugar-free oral liquid formulation containing this drug (2.0 mg/mL) in order to allow the dose adjustment, accuracy and easy administration. Methodology: The stability of formulation was evaluated at room temperature (15-30°C), refrigerated (2-8°C) and oven (40°C), during 56 days in amber glass bottles (n = 3). A stability-indicating analytical method by high performance liquid chromatography (HPLC) was used for drug determination weekly. The acceptance criterion was between 95.0% and 105.0%. Organoleptic characteristics, pH, viscosity, and microbiological content were also evaluated. Results: All samples under room and refrigerated conditions kept their pH values and microbiological content in accordance during all the period tested. However, for those at room temperature, the drug amount, formulation appearance and viscosity were adequate until the 42nd day of analysis, indicating that this was the recommended beyond-use date for the proposed solution. Conclusion: A simple and economical solution was obtained with the advantage to be sugar-free, without the cariogenic effect, and without the disadvantages of pharmaceutical suspensions, contributing to pediatric patients during hospital treatments.